References
- Fuglsang KA, Brandt CF, Scheike T, et al. Hospitalizations in patients with nonmalignant short-bowel syndrome receiving home parenteral support. Nutr Clin Pract. 2020;35(5):894–902.
- Noelting J, Gramlich L, Whittaker S, et al. Survival of patients with short‐bowel syndrome on home parenteral nutrition: a prospective cohort study. J Parenter Enter Nutr. 2020. DOI:10.1002/jpen.1984.
- Pironi L, Arends J, Baxter J, Home Artificial Nutrition & Chronic Intestinal Failure, Acute Intestinal Failure Special Interest Groups of ESPEN, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clin Nutr. 2015;34(2):171–180.
- Pironi L. Definitions of intestinal failure and the short bowel syndrome. Best Pract Res Clin Gastroenterol. 2016;30(2):173–185.
- Severijnen R, Bayat N, Bakker H, et al. Enteral drug absorption in patients with short small bowel: a review. Clin Pharmacokinet. 2004;43(14):951–962.
- Rouch JD, Dunn JCY. New insights and interventions for short bowel syndrome. Curr Pediatr Rep. 2017;5(1):1–5.
- Ward N. The impact of intestinal failure on oral drug absorption: a review. J Gastrointest Surg. 2010;14(6):1045–1051.
- Carlsson E, Bosaeus I, Nordgren S. Quality of life and concerns in patients with short bowel syndrome. Clin Nutr. 2003;22(5):445–452.
- Kumpf VJ. Pharmacologic management of diarrhea in patients with short bowel syndrome. JPEN J Parenter Enteral Nutr. 2014;38(1 Suppl):38S–44S.
- Alkilani AZ, McCrudden MTC, Donnelly RF. Transdermal drug delivery: innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum. Pharmaceutics. 2015;7(4):438–470.
- Santamaría MM, Villafranca JJA, Abilés J, et al. Systematic review of drug bioavailability following gastrointestinal surgery. Eur J Clin Pharmacol. 2018;74(12):1531–1545.
- Ladebo L, Foster DJR, Abuhelwa AY, et al. Population pharmacokinetic‐pharmacodynamic modelling of liquid and controlled‐release formulations of oxycodone in healthy volunteers. Basic Clin Pharmacol Toxicol. 2020;126(3):263–276.
- R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2014. [Internet]. [cited 2018 Dec 20]. Available from: http://www.r-project.org/.
- US Food and Drug Administration. Drug development and drug interactions: table of substrates, inhibitors and inducers. US Food and Drug Administration; 2020. [Internet]. [cited 2021 May 20]. Available from: https://www.fda.gov/drugs/drug-interactions-labeling/drug-development-and-drug-interactions-table-substrates-inhibitors-and-inducers.
- Menardi G, Guggenbichler JP. Biovailability of oral antibiotics in children with short-bowel syndrome. J Pediatr Surg. 1984;19(1):84–86.
- Faye E, Drouet L, De Raucourt E, et al. Absorption and efficacy of acetylsalicylic acid in patients with short bowel syndrome. Ann Pharmacother. 2014;48(6):705–710.
- Cheung YW, Barco S, Mathôt RAA, et al. Pharmacokinetics of dabigatran etexilate and rivaroxaban in patients with short bowel syndrome requiring parenteral nutrition: the PDER PAN study. Thromb Res. 2017;160:76–82.
- Pironi L, Steiger E, Brandt C, et al. Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: an international survey. Clin Nutr. 2020;39(2):585–591.
- Pironi L, Konrad D, Brandt C, et al. Clinical classification of adult patients with chronic intestinal failure due to benign disease: an international multicenter cross-sectional survey. Clin Nutr. 2018;37(2):728–738.
- Tappenden KA. Intestinal adaptation following resection. JPEN J Parenter Enteral Nutr. 2014;38(1 Suppl):23S–31S.
- Martinez MN, Amidon GL. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J Clin Pharmacol. 2002;42(6):620–643.
- Warner BW. The pathogenesis of resection-associated intestinal adaptation. Cell Mol Gastroenterol Hepatol. 2016;2(4):429–438.
- Jeppesen PB, Hartmann B, Thulesen J, et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut. 2000;47(3):370–376.
- Markovic MA, Brubaker PL. The roles of glucagon-like peptide-2 and the intestinal epithelial insulin-like growth factor-1 receptor in regulating microvillus length. Sci Rep. 2019;9(1):13010.
- Kinnunen M, Piirainen P, Kokki H, et al. Updated clinical pharmacokinetics and pharmacodynamics of oxycodone. Clin Pharmacokinet. 2019;58(6):705–725.